Form 4: AtriCure Director Karen Prange Sells 6,100 Shares
SEC Form 4 Filing
Director Karen Prange of AtriCure, Inc. sold 6,100 shares of common stock at an average price of $38.12 on March 5, 2025.
Summary
- On March 5, 2025, Karen Prange, a director of AtriCure, Inc. (ATRC), sold 6,100 shares of the company's common stock.
- The sale was executed at a weighted average price of $38.12 per share, with individual transactions ranging from $37.60 to $38.52.
- Following the transaction, Prange directly owns 17,828 shares of AtriCure common stock.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing reporting a stock sale by a company director. It doesn't inherently convey positive or negative sentiment.
Industry Context
This is a standard Form 4 filing, which is required when a company insider, such as a director, buys or sells shares of their company's stock. It provides transparency into the transactions of company insiders.
Stakeholder Impact
- The sale of shares by a director could be perceived negatively by some shareholders, but it is a relatively small transaction and may not have a significant impact.
Key Dates
| Date | Description |
|---|---|
| 03/05/2025 | Date of transaction: Karen Prange sold 6,100 shares of AtriCure common stock. |
| 03/07/2025 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.